155 related articles for article (PubMed ID: 9758316)
21. Critical postcraniotomy cerebrospinal fluid hypovolemia: risk factors and outcome analysis.
Komotar RJ; Ransom ER; Mocco J; Zacharia BE; McKhann GM; Mayer SA; Connolly ES
Neurosurgery; 2006 Aug; 59(2):284-90; discussion 284-90. PubMed ID: 16883169
[TBL] [Abstract][Full Text] [Related]
22. [Does the assay of acute phase protein concentrations in cerebrospinal fluid and/or in serum in patient with viral meningitis have a diagnostic value? Part II. Lymphocytic meningitis caused by echo 30 virus].
Mamełka B; Lobos M; Sass-Just M; Dworniak D; Urbaniak A; Terlecka M; Paradowski M
Przegl Epidemiol; 2004; 58(2):351-9. PubMed ID: 15517816
[TBL] [Abstract][Full Text] [Related]
23. [Serial measurement of bradykinin of the cerebrospinal fluid in patients with subarachnoid hemorrhage].
Kasuya H; Shimizu T; Okada T; Takahashi K; Summerville T; Kitamura K
No To Shinkei; 1986 Jun; 38(6):551-6. PubMed ID: 3730196
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric analysis of cerebral substrates and nitric oxide delivery in cerebrospinal fluid in patients with intracerebral haemorrhage: correlation with hemodynamics and outcome.
Chiang MF; Chiu WT; Lin FJ; Thajeb P; Huang CJ; Tsai SH
Acta Neurochir (Wien); 2006 Jun; 148(6):615-21; dicussion 621. PubMed ID: 16614805
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic activity of prazosin is decreased by alpha-1-acid glycoprotein in vivo.
Chiang J; Oie S
J Pharmacol Exp Ther; 1990 Jul; 254(1):324-9. PubMed ID: 2164099
[TBL] [Abstract][Full Text] [Related]
26. Complement activation in the central nervous system following blood-brain barrier damage in man.
Lindsberg PJ; Ohman J; Lehto T; Karjalainen-Lindsberg ML; Paetau A; Wuorimaa T; Carpén O; Kaste M; Meri S
Ann Neurol; 1996 Oct; 40(4):587-96. PubMed ID: 8871578
[TBL] [Abstract][Full Text] [Related]
27. Cerebrospinal fluid and serum chitotriosidase levels in patients with aneurysmal subarachnoid haemorrhage: preliminary results.
Işman FK; Kacira T; Kuçur M; Sanus GZ; Atukeren P; Tanriverdi T; Kaynar MY
Turk Neurosurg; 2007 Oct; 17(4):235-42. PubMed ID: 18050064
[TBL] [Abstract][Full Text] [Related]
28. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage.
Sanchez-Peña P; Pereira AR; Sourour NA; Biondi A; Lejean L; Colonne C; Boch AL; Al Hawari M; Abdennour L; Puybasset L
Crit Care Med; 2008 Aug; 36(8):2267-73. PubMed ID: 18596638
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage.
Woszczyk A; Deinsberger W; Böker DK
Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885
[TBL] [Abstract][Full Text] [Related]
30. A non-enzymatic derived arachidonyl peroxide, 8-iso-prostaglandin F2 alpha, in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage participates in the pathogenesis of delayed cerebral vasospasm.
Asaeda M; Sakamoto M; Kurosaki M; Tabuchi S; Kamitani H; Yokota M; Watanabe T
Neurosci Lett; 2005 Jan; 373(3):222-5. PubMed ID: 15619547
[TBL] [Abstract][Full Text] [Related]
31. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats.
Pentel PR; Keyler DE
J Pharmacol Exp Ther; 1988 Sep; 246(3):1061-6. PubMed ID: 3418509
[TBL] [Abstract][Full Text] [Related]
32. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
33. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model.
Hänggi D; Eicker S; Beseoglu K; Rapp M; Perrin J; Nawatny J; Turowski B; Sommer C; Steiger HJ
Neurosurgery; 2009 Jun; 64(6):1155-9; discussion 1159-61. PubMed ID: 19487896
[TBL] [Abstract][Full Text] [Related]
34. Serum free and bound sialic acid and alpha-1-acid glycoprotein in patients with laryngeal cancer.
Uslu C; Taysi S; Akcay F; Sutbeyaz MY; Bakan N
Ann Clin Lab Sci; 2003; 33(2):156-9. PubMed ID: 12817619
[TBL] [Abstract][Full Text] [Related]
35. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
Arredondo G; Martinez-Jorda R; Calvo R; Aguirre C; Suarez E
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
[TBL] [Abstract][Full Text] [Related]
36. Use of ventricular cerebrospinal fluid lactate measurement to diagnose cerebrospinal fluid infection in patients with intraventricular haemorrhage.
Wong GK; Poon WS; Ip M
J Clin Neurosci; 2008 Jun; 15(6):654-5. PubMed ID: 18342513
[TBL] [Abstract][Full Text] [Related]
37. Serum protein binding of lerisetron, a novel specific 5HT3 antagonist, in patients with cancer.
Calvo R; Jiménez RM; Trocóniz IF; Suárez E; Gonzalo A; Lucero ML; Raczka E; Orjales A
Cancer Chemother Pharmacol; 1998; 42(5):418-22. PubMed ID: 9771958
[TBL] [Abstract][Full Text] [Related]
38. Mass spectrometry-based method for quantification of nimodipine and glutamate in cerebrospinal fluid. Pilot study with patients after aneurysmal subarachnoid haemorrhage.
Mindt S; Tokhi U; Hedtke M; Groß HJ; Hänggi D
J Clin Pharm Ther; 2020 Feb; 45(1):81-87. PubMed ID: 31421063
[TBL] [Abstract][Full Text] [Related]
39. Effect of peritonitis on plasma and dialysate alpha 1-acid glycoprotein concentrations in peritoneal dialysis patients.
Bohenek WS; Johnson CA; Ateshkadi A; Oxton LL; Zimmerman SW
Clin Pharm; 1993 Aug; 12(8):602-5. PubMed ID: 8222525
[TBL] [Abstract][Full Text] [Related]
40. Decreased elimination of unbound prazosin in the presence of alpha 1-acid glycoprotein in the rat in vivo.
Oie S; Fiori F; Chiang J
J Pharmacol Exp Ther; 1987 Jun; 241(3):934-8. PubMed ID: 3598910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
